The Blüm Study is a Phase 3 clinical research study for autism that currently is enrolling across the United States. Children ages 3 to 8 are eligible to enroll.
Investigators want to see if the study medication, CM-AT, may help improve symptoms of Autism. Researchers will evaluate children using psychological, medical, behavioral and developmental measures — without using pills or needles. For more information on the study, click here.